Table 1. Demographic and Clinical Characteristics of Participants in Experiments 1 and 2.
| Characteristic | Experiment 1 | Experiment 2 | ||
| OCD Patients a , b | Non-Patient Controls | OCD Patients c , d | Non-Patient Control | |
| Age (years) | 33.95±9.38 | 31.16±7.53 | 29.62±6.78 | 29.80±6.38 |
| Total Score on Padua-R | 51.49±9.60 | 18.77±4.44 | 52.63±6.24 | 20.40±4.36 |
| Contamination subscale, Padua-R | 20.19±5.79 | 7.47±2.58 | 9.38±2.18 | 7.47±2.64 |
| Checking subscale, Padua-R | 9.49±3.18 | 7.25±2.71 | 8.20±2.70 | 24.38±3.71 |
Values are mean±SD.
a
Comorbid diagnoses: None (70.2%), major depressive disorder (15.8%), generalized anxiety disorder (8.8%), alcohol abuse (7.9%).
b
Psychotropic medications: None (21.1%), paroxetine or fluoxetine (35.1%), clonazepam (22.8%), citalopram or escitalopram (14.0%).
c
Comorbid diagnoses: None (53.8%), major depressive disorder (23.1%), generalized anxiety disorder (23.1%).
d
Psychotropic medications: None (15.4%), paroxetine or fluoxetine (38.5%), clonazepam (15.4%), citalopram or escitalopram (15.4%).